Suit Claims Illumina's Sequencer Infringes DNA Amplification Patent | GenomeWeb

NEW YORK (GenomeWeb News) – A suit filed in the US District Court for the District of Delaware today claims that Illumina's Genome Analyzer and related products and services infringe a patent originally issued to Genelabs and now held by a firm called LadaTech.

According to court documents, LadaTech has accused Illumina of infringing US Patent 6,107,023, "DNA Amplification and Subtraction Techniques," which was issued in 2000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.